New

Europe Acute Lung Injury Market

2021

Europe Acute Lung Injury Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapy (Mechanical Ventilation, Fluid Management, Pharmacotherapy, and Adjunctive Procedures) and End User (Hospitals, Ambulatory Surgery Centers, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025719 | No. of Pages: 102 | Category: Pharmaceuticals | Status: Published

Market Insights

Europe Acute Lung Injury Market to Grow at a CAGR of 4.4% to reach US$ 211.12 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Europe acute lung injury market is expected to grow from US$ 156.55 million in 2021 to US$ 211.12 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028.

The UK, Germany, France, Italy, and Spain are major economies in Europe. Growing prevalence of respiratory diseases is expected to fuel the market growth. The high prevalence of respiratory conditions is associated with the decrease in the size of the upper airway lumen in the aging population. Lung disorders are among the most common medical conditions across the region. People suffer from various sorts of respiratory diseases. Smoking, infections, and genetic factors are among the common factors responsible for respiratory disorders. Medical conditions such as COPD, asthma, chronic bronchitis, cystic fibrosis, and lung cancer are significant public health burdens. In addition, the World Health Organization (WHO) states that millions of people die from lung cancer every year, making it the most common lethal infectious disease. In addition, 91% of the population lives in cities and places where the air quality is not optimum, as recommended by the WHO. Patients suffering from these respiratory disorders commonly experience difficulty in breathing. The respiratory failure associated with acute lung injury, or the acute respiratory distress syndrome (ARDS) is one of the most critical contributors to postoperative mortality. Moreover, state, and local health departments, and other clinical and public health associates continue to monitor smoking e-cigarette or vaping product use associated lung injury (EVALI). Thus, all the above-mentioned factors are expected to result in the growth of the Europe acute lung injury market during the forecast period.

In case of COVID-19, Spain, Italy, Germany, France, and the UK are among the most affected European countries. As per the Worldometer, as of September 16, 2021, Spain, UK, Italy, Germany, and France recorded 4,922,249; 7,312,683; 4,618,040; 4,117,263; and 6,926,604, respectively, COVID-19 cases, and the deaths toll is also high in these countries. In addition, Novel coronavirus-associated disease (COVID-19) was first detected in Spain on 31 January 2020, with more than 204 178 cases subsequently identified in 3 months.1 Severe COVID-19 is associated with high circulating levels of inflammatory cytokines akin to a cytokine release syndrome that frequently results in respiratory failure. To date, scant histopathological information of infected patients is available. Few descriptions of histopathological findings have mainly reported pneumonitis and diffuse alveolar damage (DAD).2–5 To advance in the knowledge of COVID-19-associated tissue damage is important to understand the mechanisms of damage caused by SARS-COV-2.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe acute lung injury market. The Europe acute lung injury market is expected to grow at a good CAGR during the forecast period.
Europe acute lung injury market

Get more information on this report :


Europe Acute Lung Injury Market Segmentation
Europe Acute Lung Injury Market – By Therapy

  • Mechanical Ventilation
  • Fluid Management
  • Pharmacotherapy
  • Adjunctive Procedures

Europe Acute Lung Injury Market – By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Europe Acute Lung Injury Market, by Country

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe

Europe Acute Lung Injury Market - Companies Mentioned

  • Apeiron Biologics AG
  • APEPTICO Forschung und Entwicklung GmbH
  • GlaxoSmithKline Plc
  • Histocell
  • Stemedica Cell Technologies, Inc
  • Windtree Therapeutics, Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Acute Lung Injury Market – By Therapy

1.3.2 Europe Acute Lung Injury Market – By End User

1.3.3 Europe Acute Lung Injury Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Acute Lung Injury Market– Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Acute Lung Injury Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Respiratory Diseases

5.1.2 Increasing Geriatric Population

5.2 Market Restraints

5.2.1 Overpriced Therapies

5.3 Market Opportunities

5.3.1 Surging Technological Advancements by Market Players

5.4 Future Trends

5.4.1 Escalating Pipeline Drugs

5.5 Impact Analysis

6. Acute Lung Injury Market– Europe Analysis

6.1 Europe Acute Lung Injury Market Revenue Forecast and Analysis

7. Europe Acute Lung Injury Market Analysis – By Therapy

7.1 Overview

7.2 Europe Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)

7.3 Mechanical Ventilation

7.3.1 Overview

7.3.2 Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Fluid Management

7.4.1 Overview

7.4.2 Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Pharmacotherapy

7.5.1 Overview

7.5.2 Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Adjunctive Procedures

7.6.1 Overview

7.6.2 Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Acute Lung Injury Market Analysis – By End User

8.1 Overview

8.2 Europe Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Ambulatory Surgery Centers

8.4.1 Overview

8.4.2 Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Acute Lung Injury Market – Country Analysis

9.1 Europe: Acute Lung Injury Market

9.1.1 Overview

9.1.2 Europe: Acute Lung Injury Market, by Country, 2021 & 2028(%)

9.1.2.1 Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.1 Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.2 Germany: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.1.3 Germany: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.2 France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.1 France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.2 France: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.2.3 France: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.3 UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.1 UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.2 UK: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.3.3 UK: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.4 Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.1 Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.2 Italy: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.4.3 Italy: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.5 Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.1 Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.2 Spain: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.5.3 Spain: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.6 Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.1 Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.2 Rest of Europe: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.6.3 Rest of Europe: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Europe Acute Lung Injury Market

10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 GlaxoSmithKline Plc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Stemedica Cell Technologies, Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Histocell

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 APEPTICO Forschung und Entwicklung GmbH

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Windtree Therapeutics, Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Apeiron Biologics AG

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Germany: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 4. France: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 5. France: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 6. UK: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 7. UK: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8. Italy: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 9. Italy: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10. Spain: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 11. Spain: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. Rest of Europe: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 13. Rest of Europe: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14. Organic Developments Done by Companies

Table 15. Inorganic Developments Done by Companies

Table 16. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Acute Lung Injury Market Segmentation

Figure 2. Europe Acute Lung Injury Market Segmentation, By Country

Figure 3. Europe Acute Lung Injury Market Overview

Figure 4. Mechanical Ventilation Segment Held the Largest Share of the Market in 2021

Figure 5. The UK to Show Significant Growth During Forecast Period

Figure 6. Europe and PEST Analysis

Figure 7. Europe Acute Lung Injury Market Impact Analysis of Driver and Restraints

Figure 8. Europe Acute Lung Injury Market– Revenue Forecast and Analysis

Figure 9. Europe Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)

Figure 10. Europe Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Europe Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Europe Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Europe Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Europe Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)

Figure 15. Europe Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Europe Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Europe Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Europe: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million)

Figure 19. Europe: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

Figure 20. Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 21. France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 22. UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 23. Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 24. Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 25. Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 26. Impact of COVID-19 Pandemic in European Country Markets

  1. Apeiron Biologics AG
  2. APEPTICO Forschung und Entwicklung GmbH
  3. GlaxoSmithKline Plc
  4. Histocell
  5. Stemedica Cell Technologies, Inc
  6. Windtree Therapeutics, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe acute lung injury market. 
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe acute lung injury market, thereby allowing players across the value chain to develop effective long-term strategies    
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the acute lung injury market, as well as those hindering it  
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025719
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.